Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Nutraplus India Ltd
Your Vote -
Buy
66.67%
Hold
0.00%
Sell
33.33%
66.67%
3 users have voted
Option Chain
Analyzes market sentiment, predicts Nutraplus India Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
No Records Found
Key fundamentals
Evaluate the intrinsic value of Nutraplus India Ltd stock
Name | March-23 | March-22 | March-21 | March-20 | March-19 |
---|---|---|---|---|---|
Assets | -3.4753 | -3.3296 | -0.2982 | 97.4895 | 136.3093 |
Liabilities | -3.4753 | -3.3296 | -0.2982 | 97.4895 | 136.3093 |
Equity | 17.0455 | 17.0455 | 17.0455 | 17.0455 | 17.0455 |
Gross Profit | -0.1278 | -3.6514 | -0.7023 | -35.8366 | 12.6536 |
Net Profit | -0.157 | -3.0313 | -24.5161 | -47.8261 | 2.1893 |
Cash From Operating Activities | 0.0166 | -0.1328 | -14.2531 | 9.0697 | 12.362 |
NPM(%) | 0 | -3091.9 | -124955.078 | -44.83 | 1.56 |
Revenue | 0 | 0.098 | 0.0196 | 106.6681 | 139.5559 |
Expenses | 0.1278 | 3.7494 | 0.7219 | 142.5047 | 126.9023 |
ROE(%) | 2.99 | 57.86 | 468 | 912.98 | -41.79 |
Corporate Action
XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
---|
Peers
Other companies within the same industry or sector that are comparable to Nutraplus India Ltd
Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
---|---|---|---|---|---|---|
Albert David Ltd | 824.20 | -1.99 | 11.65 | 1.20 | 1321.50 | 1.39 |
Lotus Eye Hospital and Institute Ltd | 80.41 | -0.74 | 338.42 | 4.37 | 14.01 | 0.62 |
Bharat Immunological and Biologicals Corporation Ltd | 23.00 | -1.41 | 0.00 | 9.07 | -39.50 | 0.00 |
Astec Lifesciences Ltd | 681.00 | -1.58 | 0.00 | 4.12 | -687.11 | 0.00 |
Company Info
NUTRAPLUS PRODUCTS (INDIA) LIMITED was originally incorporated as a private limited company on 6th February 1990 with the Registrar of Companies, Maharashtra at Bombay. It was subsequently converted into a Public Limited Company with effect from 13th June 1992 in terms of the resolution passed in the Extra Ordinary General Meeting of the Company held on 28th May 1992. The Company is implementing a project for the manufacture of veterinary bulk drugs namely Dimetridazole (DMZ) and Dinitolmide (DOT) at M.I.D.C., Tarapur. Initially the Company proposed to set up manufacturing facilities for manufacture of Methyl Nitro Imidazole, an intermediate of DMZ with installed capacity of 240 MT per annum at a cost of Rs.123.66 Lakhs, for which it was sanctioned a term Loan of Rs.60 Lakhs from Maharashtra State Financial Corporation (MSFC). But now the Company has decided to go in for production of Dimetridazole (DMZ) and Dinitolmide (DOT) with installed capacities of 160 MT and 300 MT respectively per annum due to high value addition in these products, than their intermediates, huge demand and export potential for these products, being veterinary bulk drugs and there being few units manufacturing these bulk drugs in the organised sector and also because these products are not under any government controls with regard to manufacturing, pricing, selling or distribution unlike other bulk drugs. 2014 -Company has changed its name from Nutraplus Products (India) Ltd to Nutraplus India Ltd. 2015 -The Company have opened a corporate office Nutraplus India Limited 201/202, 2nd Floor, Planet Industrial Estate, Subhash Road, Vile Parle (East), Mumbai - 400057. Whereas the Registered Office of the Company will remain the same i.e.:Nutraplus India Limited,Vakil Villa, 7-A, Society Road End, Jogeshwari (E), Mumbai - 400060 2016 -Nutraplus India as commenced commercial production in its new plant at Tarapur for anti-malarial drug LUMEFANTRINE.
NUTRAPLUS PRODUCTS (INDIA) LIMITED was originally incorporated as a private limited company on 6th February 1990 with the Registrar of Companies, Maharashtra at Bombay. It was subsequently converted into a Public Limited Company with effect from 13th June 1992 in terms of the resolution passed in the Extra Ordinary General Meeting of the Company held on 28th May 1992. The Company is implementing a project for the manufacture of veterinary bulk drugs namely Dimetridazole (DMZ) and Dinitolmide (DOT) at M.I.D.C., Tarapur. Initially the Company proposed to set up manufacturing facilities for manufacture of Methyl Nitro Imidazole, an intermediate of DMZ with installed capacity of 240 MT per annum at a cost of Rs.123.66 Lakhs, for which it was sanctioned a term Loan of Rs.60 Lakhs from Maharashtra State Financial Corporation (MSFC). But now the Company has decided to go in for production of Dimetridazole (DMZ) and Dinitolmide (DOT) with installed capacities of 160 MT and 300 MT respectively per annum due to high value addition in these products, than their intermediates, huge demand and export potential for these products, being veterinary bulk drugs and there being few units manufacturing these bulk drugs in the organised sector and also because these products are not under any government controls with regard to manufacturing, pricing, selling or distribution unlike other bulk drugs. 2014 -Company has changed its name from Nutraplus Products (India) Ltd to Nutraplus India Ltd. 2015 -The Company have opened a corporate office Nutraplus India Limited 201/202, 2nd Floor, Planet Industrial Estate, Subhash Road, Vile Parle (East), Mumbai - 400057. Whereas the Registered Office of the Company will remain the same i.e.:Nutraplus India Limited,Vakil Villa, 7-A, Society Road End, Jogeshwari (E), Mumbai - 400060 2016 -Nutraplus India as commenced commercial production in its new plant at Tarapur for anti-malarial drug LUMEFANTRINE.
Read More
Parent Organisation
Nutraplus India Ltd.
Founded
06/02/1990
Managing Director
Mr.Mukesh D Naik
NSE Symbol
FAQ
The current price of Nutraplus India Ltd is
The 52-week high for Nutraplus India Ltd is
The market capitalization of Nutraplus India Ltd is currently
This value can fluctuate based on stock price movements and changes in the number of shares outstanding.To buy Nutraplus India Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Nutraplus India Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Nutraplus India Ltd shares.
The CEO of Nutraplus India Ltd is Mr.Mukesh D Naik, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.